πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 763 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7371364

Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy

The Board of Regents of the University of Texas System Β· Granted Tue May 13 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 08 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7338758

Compositions and methods for the identification, assessment, prevention and therapy of hum

The Board of Regents of the University of Texas System Β· Granted Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7326697

Methods for increasing the therapeutic response to electroconvulsive therapy

Corcept Therapeutics Incorporated Β· Granted Tue Feb 05 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 31 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7314911

Prostate hyperplasia therapy

The Board of Regents of the University of Texas System Β· Granted Tue Jan 01 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7312202

Rationally designed and chemically synthesized promoter for genetic vaccine and gene thera

The Board of Regents of the University of Texas System Β· Granted Tue Dec 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7309694

Modified cytokines for use in cancer therapy

FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR Β· Granted Tue Dec 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7306914

Protein fragment complementation assays in whole animals applications to drug efficacy, AD

Odyssey Thera Inc. Β· Granted Tue Dec 11 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 06 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7300940

Integrin Ξ±-v Ξ²-3 antagonists for use in imaging and therapy

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Nov 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7291699

Product and methods for diagnosis and therapy for cardiac and skeletal muscle disorders

The Regents of the University of Colorado Β· Granted Tue Nov 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7285527

Tumor radiosensitization using gene therapy

The Regents of the University of California Β· Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7285542

Hyperthermic inducible expression vectors for gene therapy and methods of use thereof

Arizona Board of Regents on Behalf of the University of Arizona Β· Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7273613

Diagnostics and therapy of Epstein-Barr virus in autoimmune disorders

The Board of Regents of the University of Oklahoma Β· Granted Tue Sep 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7264820

Cancer immunotherapy using autologous tumor cells combined with cells expressing a membran

The Regents of the University of California Β· Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7244423

Methods for therapy of neurodegenerative disease of the brain

The Regents of the University of California Β· Granted Tue Jul 17 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 12 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7238525

Strategy for leukemia therapy

The Regents of the University of California Β· Granted Tue Jul 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7227010

Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use

The United States of America as represented by the Secretary of the Army Β· Granted Tue Jun 05 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7223388

Modified reoviral therapy

The Board of Regents of the University of Texas System Β· Granted Tue May 29 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 24 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7217571

Gene therapy by small fragment homologous replacement

The Regents of the University of California Β· Granted Tue May 15 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7198783

Sensitization of neoplastic cells to radiation therapy with reovirus

ONCOLYTICS BIOTECH INC. Β· Granted Tue Apr 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7198788

Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing C

The Board of Regents of the University of Texas System Β· Granted Tue Apr 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7175830

Imaging of drug accumulation as a guide to antitumor therapy

The United States of America, as represented by the Secretary, Health and Human Services Β· Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7173007

Therapy for microbial infections

The United States of America as represented by the Department of Veteran Affairs Β· Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7163925

p16 expression constructs and their application in cancer therapy

The Board of Regents of the University of Texas System Β· Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7153514

Use of botulinum toxin therapy for prostatic hyperplasia and related disorders

The Regents of the University of Colorado Β· Granted Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

granted